These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 22264220

  • 1. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department.
    Nickel CH, Bingisser R, Morgenthaler NG.
    BMC Med; 2012 Jan 20; 10():7. PubMed ID: 22264220
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic significance of hypothalamic-pituitary-adrenal axis hormones in early sepsis: a study performed in the emergency department.
    Zhang Q, Dong G, Zhao X, Wang M, Li CS.
    Intensive Care Med; 2014 Oct 20; 40(10):1499-508. PubMed ID: 25223852
    [Abstract] [Full Text] [Related]

  • 4. Copeptin and its potential role in diagnosis and prognosis of various diseases.
    Dobsa L, Edozien KC.
    Biochem Med (Zagreb); 2013 Oct 20; 23(2):172-90. PubMed ID: 23894863
    [Abstract] [Full Text] [Related]

  • 5. Copeptin as a biomarker in cardiac disease.
    Giannopoulos G, Deftereos S, Panagopoulou V, Kossyvakis C, Kaoukis A, Bouras G, Pyrgakis V, Cleman MW.
    Curr Top Med Chem; 2013 Oct 20; 13(2):231-40. PubMed ID: 23470080
    [Abstract] [Full Text] [Related]

  • 6. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
    Maisel A, Xue Y, Shah K, Mueller C, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand IS, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.
    Circ Heart Fail; 2011 Sep 20; 4(5):613-20. PubMed ID: 21765124
    [Abstract] [Full Text] [Related]

  • 7. Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress.
    Kacheva S, Kolk K, Morgenthaler NG, Brabant G, Karges W.
    Clin Endocrinol (Oxf); 2015 Apr 20; 82(4):570-6. PubMed ID: 25200793
    [Abstract] [Full Text] [Related]

  • 8. Copeptin: a biomarker of cardiovascular and renal function.
    Morgenthaler NG.
    Congest Heart Fail; 2010 Jul 20; 16 Suppl 1():S37-44. PubMed ID: 20653710
    [Abstract] [Full Text] [Related]

  • 9. Copeptin in Heart Failure.
    Balling L, Gustafsson F.
    Adv Clin Chem; 2016 Jul 20; 73():29-64. PubMed ID: 26975969
    [Abstract] [Full Text] [Related]

  • 10. Copeptin: a new and promising diagnostic and prognostic marker.
    Katan M, Müller B, Christ-Crain M.
    Crit Care; 2008 Jul 20; 12(2):117. PubMed ID: 18355399
    [Abstract] [Full Text] [Related]

  • 11. Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction.
    Pozsonyi Z, Förhécz Z, Gombos T, Karádi I, Jánoskuti L, Prohászka Z.
    Heart Lung Circ; 2015 Apr 20; 24(4):359-67. PubMed ID: 25618448
    [Abstract] [Full Text] [Related]

  • 12. Copeptin levels and invasive hemodynamics in patients with advanced heart failure.
    Balling L, Goetze JP, Jung MH, Rossing K, Boesgaard S, Gustafsson F.
    Biomark Med; 2018 Aug 20; 12(8):861-870. PubMed ID: 30058349
    [Abstract] [Full Text] [Related]

  • 13. Copeptin as a marker of an altered CRH axis in pituitary disease.
    Lewandowski KC, Lewiński A, Skowrońska-Jóźwiak E, Malicka K, Horzelski W, Brabant G.
    Endocrine; 2017 Sep 20; 57(3):474-480. PubMed ID: 28795329
    [Abstract] [Full Text] [Related]

  • 14. Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
    Düngen HD, Tscholl V, Obradovic D, Radenovic S, Matic D, Musial Bright L, Tahirovic E, Marx A, Inkrot S, Hashemi D, Veskovic J, Apostolovic S, von Haehling S, Doehner W, Cvetinovic N, Lainscak M, Pieske B, Edelmann F, Trippel T, Loncar G.
    ESC Heart Fail; 2018 Apr 20; 5(2):288-296. PubMed ID: 29476612
    [Abstract] [Full Text] [Related]

  • 15. Copeptin: a diagnostic factor for critical patients.
    Yilman M, Erenler AK, Baydin A.
    Eur Rev Med Pharmacol Sci; 2015 Aug 20; 19(16):3030-6. PubMed ID: 26367724
    [Abstract] [Full Text] [Related]

  • 16. Potential Clinical Utility of Copeptin (C-terminal provasopressin) measurements in clinical medicine.
    Lewandowski KC, Brabant G.
    Exp Clin Endocrinol Diabetes; 2016 Mar 20; 124(3):173-7. PubMed ID: 27008633
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of Arginine on the Hypothalamic-Pituitary-Adrenal Axis in Individuals With and Without Vasopressin Deficiency.
    Bologna K, Cesana-Nigro N, Refardt J, Imber C, Vogt DR, Christ-Crain M, Winzeler B.
    J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32236441
    [Abstract] [Full Text] [Related]

  • 20. Plasma copeptin levels in patients with restless legs syndrome.
    Topaloglu Tuac S, Ozben S, Koseoglu Bitnel M, Koksal A, Kucuksayan E, Hanikoğlu A, Ozben T.
    Acta Neurol Scand; 2018 Mar 01; 137(3):316-320. PubMed ID: 29148047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.